A revised version of the US Centers for Disease Control and Prevention’s coronavirus diagnostic was reauthorized by the Food and Drug Administration on 15 March, FDA commissioner Stephen Hahn announced in a 16 March series of tweets.
The CDC’s test, known as the CDC 2019-Novel Coronavirus Real-Time Reverse Transcriptase RT-PCR Diagnostic Panel, was initially authorized by the...